(Q33806419)

29 July 2017

1 reference

title

Cryoglobulinemic vasculitis (English)

1 reference

29 July 2017

Lamprecht P

1

1 reference

29 July 2017

Gause A

series ordinal

2

1 reference

29 July 2017

Gross WL

series ordinal

3

1 reference

29 July 2017

publication date

1 December 1999

1 reference

29 July 2017

published in

Arthritis & Rheumatology

1 reference

29 July 2017

volume

42

1 reference

29 July 2017

issue

12

1 reference

29 July 2017

page(s)

2507-2516

1 reference

Biologic and clinical significance of cryoglobulins. A report of 86 cases

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Mixed cryoglobulinaemia after hepatitis C virus: more and less ambiguity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Cryoglobulins are not essential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Hepatitis C virus in patients with cryoglobulinemia type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

A role for hepatitis C virus infection in type II cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Hepatitis C virus infection in patients with essential mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

A clinical and virological study of hepatitis C virus-related cryoglobulinemia in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Hepatitis G and mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Monoclonal lymphocyte proliferation and bcl-2 rearrangement in essential mixed cryoglobulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Binding of hepatitis C virus to CD81

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Hepatitis C virus infection and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Hepatitis C virus infection in patients with non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Detection of hepatitis C virus RNA in CD19 peripheral blood mononuclear cells of chronically infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

A non-retroviral RNA virus persists in DNA form

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Hepatitis C virus (HCV)-induced IgG-IgM rheumatoid factor (RF) complex may be the main causal factor for cold-dependent activation of complement in patients with rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Mixed cryoglobulinaemia, glomerulonephritis, and ANCA: essential cryoglobulinaemic vasculitis or ANCA-associated vasculitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

The pathogenesis of cryoglobulinemic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Cryoglobulinemia--a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Cryoglobulinemia and hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Interferon for hepatitis C virus-negative type II mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Therapeutic approaches in mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

New concepts in treatment protocols for severe systemic vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinaemia and hepatitis C virus (HCV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199912%2942%3A12%3C2507%3A%3AAID-ANR2%3E3.0.CO%3B2-%23

10.1002/1529-0131(199912)42:12<2507::AID-ANR2>3.0.CO;2-#

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference